• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RF ablation sets sights on breast cancer

Article

Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.

Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.

Using RFA to treat tumors in 26 patients with biopsy-proven T1 and T2 breast carcinoma, researchers in Italy and at the University of Texas M.D. Anderson Cancer Center aimed for complete ablation and a 5-mm margin. They achieved complete tumor necrosis in 25 of 26 patients, or 96%.

Traditional surgery, such as lumpectomy, usually takes about an hour. Researchers reported a mean treatment time for two-phase RFA of 15 minutes and 23 seconds.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.